Effect of statin (HMG-Co-A-reductase inhibitor) use on 1-year mortality and hospitalization rates in older patients with cardiovascular disease living in nursing homes

Journal of the American Geriatrics Society

Volumn 50, Issue 8, 2002, Pages 1389-1395

  Eaton, Charles B ^a,d   Lapane, Kate L ^b   Murphy, John B ^a   Hume, Anne L ^a,c  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF RHODE ISLAND   (United States)

^d MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

Author keywords

All cause mortality; Cardiovascular disease; Functional decline; Older; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; STATINE DERIVATIVE;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NURSING HOME; PHYSICAL CAPACITY; PREVALENCE; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HOMES FOR THE AGED; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MAINE; MALE; MISSISSIPPI; NEW YORK; NURSING HOMES; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SOUTH DAKOTA; TIME FACTORS;

EID: 0036678196     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.2002.50360.x     Document Type: Article

References (41)

1. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years old
2. Total serum cholesterol and mortality risk as a function of age
3. Ischemic heart disease risk factors after age 50
4. Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly: The Bronx aging study
5. Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 or older
6. High blood cholesterol in elderly men and the excess risk for coronary heart disease in the elderly?
7. Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly?
8. Predictors of cardiovascular events and mortality in the systolic hypertension in the elderly program pilot project
9. Cholesterol and heart disease in older persons and women: Review of an NHLBI workshop
10. Measurement and prevention of hyperlipidemia for primary prevention of coronary heart disease
11. Randomized trial of cholesterol lowering in 4,444 patients with coronary hearr disease: The Scandinavian Simvastatin Survival Study (4S)
12. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
13. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range: Results of the Cholesterol and Recurrent Events (CARE) Trial
14. Cholesterol lowering in the elderly population
15. Effect of statins on risk of coronary disease: A meta-analysis of randomized controlled trials
16. The SAGE database: Introducing functional outcomes in geriatric pharmaco-epidemiology
17. Validity of diagnostic and drug data in standardized nursing home assessments: Potential for geriatric pharmacoepidemiology
18. Characteristics of the SAGE database: A new resource for research on outcomes in long-term care
19. Prevalence, clinical correlates and treatment of hypertension in elderly nursing home residents
20. Effects of angiotensin converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure
21. Antiischemic therapy in patients with coronary heart disease in long-term care
22. Management of pain in elderly patients with cancer
23. Facility characteristics associated with hospitalization of nursing home residents: Results of a national study
24. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial
25. The use of statins in acute coronary syndrome: The mechanisms behind the outcomes
26. Association of the resident assessment instrument (RAI) with changes in function, cognition, and psychosocial status
27. Nonparametric estimation from incomplete observations
28. Statistical aspects of the analysis of data from retrospective studies of disease
29. Calculating the number needed to treat for trials where the outcome is time to an event
30. Coding of acute myocardial infarction. Clinical and policy implications
31. Possible influence of the prospective payment system on the assignment of discharge diagnoses for coronary heart disease
32. Sex-specific trends in validated CHD rates in southeastern New England 1980-1991
33. Demographics of the prevalence, incidence, and management of coronary heart disease in the elderly and in women
34. Coronary heart disease at 70, 75, and 79 years of age: A longitudinal study with special reference to sex differences and mortality
35. Coronary heart disease in the elderly
36. Age-related trends in cardiovascular disease morbidity and physical functioning in the elderly: The Cardiovascular Health Study
37. Reliability estimates for the Minimum Data Set (MDS) for nursing home resident assessment and care screening
38. Randomized clinical trials and recent patterns in the use of statins
39. Use of cholesterol-lowering medications in the United States from 1991 to 1997